SLC1A4 Gene

Migration, Crosslink

📖

SLC1A4 Gene

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-slc1a4

📖 Wiki Page

gene1807 wordssynced 2026-04-02

SLC1A4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC1A4 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC1A4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SLC1A4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SLC1A4" target="_blank">Search NCBI</a></td>
</tr>
</table>

SLC1A4 Gene

Introduction

...

SLC1A4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC1A4 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC1A4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SLC1A4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SLC1A4" target="_blank">Search NCBI</a></td>
</tr>
</table>

SLC1A4 Gene

Introduction

SLC1A4 (Solute Carrier Family 1 Member 4), also known as ASCT1 (Alanine, Serine, Cysteine Transporter 1), is a sodium-dependent neutral amino acid transporter that plays critical roles in neuronal development, brain metabolism, and cellular homeostasis[@amino2017][@slc2020]. ASCT1 is a member of the SLC1 family of amino acid transporters, which also includes the excitatory amino acid transporters (EAATs) that transport glutamate[@glutamate2002].

The SLC1A4 gene encodes a protein of 554 amino acids that functions as a system ASC (alanine, serine, cysteine) transporter, mediating the sodium-dependent uptake of neutral amino acids including serine, alanine, cysteine, and threonine[@heteromeric2005][@transporter2017]. This transporter is essential for maintaining amino acid homeostasis in the brain and other tissues.

Gene Structure and Chromosomal Location

The SLC1A4 gene is located on chromosome 2p15, a region that has been implicated in various neurological and developmental disorders[@crossspecies2003]. The gene spans approximately 22 kb and consists of multiple exons that encode the ASCT1 protein.

Gene Overview

Gene Symbol: SLC1A4
Protein Name: ASCT1 (Alanine, Serine, Cysteine Transporter 1)
Chromosomal Location: 2p15[@heteromeric2005]
NCBI Gene ID: 6509
OMIM: 600235
Ensembl ID: ENSG00000135506
UniProt: P47821

The ASCT1 protein is a member of the heteromeric amino acid transporter (HAT) family, which requires assembly with a heavy chain (4F2hc/SLC3A2) for proper plasma membrane localization and function[@heteromeric2005].

Protein Structure and Function

Structural Organization

ASCT1 is a polytopic membrane protein with multiple transmembrane domains that form the substrate translocation pore[@transporter2017]. The protein belongs to the SLC1 family, which shares a common fold and transport mechanism. The transporter contains:

N-terminal extracellular domain: Involved in substrate recognition
Multiple transmembrane helices: Form the channel pore
C-terminal intracellular domain: Involved in regulation and trafficking

The structural arrangement allows for the sodium-coupled transport of neutral amino acids in an electroneutral fashion—each amino acid molecule is transported together with one sodium ion, with no net charge movement[@amino2017].

Substrate Specificity

ASCT1 transports neutral amino acids with high affinity for:

Serine: The primary physiological substrate, essential for protein synthesis and metabolic pathways[@serine2018]
Alanine: Important for gluconeogenesis and nitrogen transport
Cysteine: Critical for glutathione synthesis and antioxidant defense[@cysteine2019]
Threonine: Essential amino acid for protein synthesis

The transporter operates as a strict exchanger, exchanging extracellular amino acids for intracellular ones, which helps maintain intracellular amino acid pools[@amino2017].

Role in Brain Function

Neuronal Amino Acid Transport

SLC1A4/ASCT1 plays a crucial role in neuronal amino acid homeostasis[@brain2022]. The brain requires precise regulation of amino acid levels for:

Neurotransmitter synthesis: Serine is a precursor for glycine and D-serine, both important neurotransmitters[@serine2018]

Protein synthesis: All neurons require continuous amino acid supply for maintenance and function

Metabolic fuel: Amino acids serve as metabolic substrates for energy production

Astrocyte Function

ASCT1 is highly expressed in astrocytes, where it plays a critical role in astrocyte-neuron metabolic coupling[@glia2018]. Astrocytes take up serine from the bloodstream via ASCT1 and provide it to neurons for:

Neurotransmitter synthesis
Glutathione precursor supply
Membrane lipid synthesis (via phosphatidylserine)[@lipid2019]

Blood-Brain Barrier Transport

At the blood-brain barrier, ASCT1 contributes to the import of neutral amino acids into the brain[@bloodbrain2015]. The combined activity of various amino acid transporters ensures that the brain receives adequate supplies of essential and non-essential amino acids for normal function.

Role in Neurodegenerative Diseases

Neurometabolic Disorders

Mutations in SLC1A4 cause a distinct neurometabolic disorder characterized by:

Microcephaly: Reduced head circumference due to impaired brain development[@spastic2015]
Spastic Paraplegia: Progressive motor impairment due to upper motor neuron degeneration
Developmental delay: Intellectual disability and delayed milestones
Growth retardation: Poor overall physical development

These mutations disrupt the normal function of ASCT1, leading to impaired serine transport and subsequent metabolic dysfunction in the developing brain[@asct12015].

Alzheimer's Disease

Altered amino acid transport may contribute to AD pathology in several ways:

Serine metabolism: Impaired serine transport affects D-serine synthesis, which modulates NMDA receptor activity important for synaptic plasticity and memory[@aminoacidneuro2019].

Glutathione synthesis: Reduced cysteine uptake compromises cellular antioxidant capacity, making neurons more vulnerable to oxidative stress[@cysteine2019].

Lipid metabolism: Altered serine availability affects phosphatidylserine synthesis, important for neuronal membrane integrity[@lipid2019].

Parkinson's Disease

SLC1A4 and other amino acid transporters may be affected in PD:

Energy metabolism: Altered amino acid transport can affect mitochondrial function and neuronal energy supply.

Neuroprotection: Reduced cysteine uptake compromises glutathione synthesis, potentially increasing vulnerability to oxidative stress[@metabolism2021].

Dopamine synthesis: Amino acid availability affects precursor supply for neurotransmitter synthesis.

Amyotrophic Lateral Sclerosis (ALS)

Amino acid transporter dysfunction has been implicated in ALS:

Excitotoxicity: Altered transport may affect glutamate homeostasis.

Metabolic dysfunction: Impaired amino acid supply affects neuronal energy metabolism.

Oxidative stress: Reduced antioxidant capacity due to compromised cysteine transport.

Multiple Sclerosis

ASCT1 in oligodendrocytes is important for myelination:

Myelin synthesis requires large amounts of serine and other amino acids
Impaired transport may contribute to demyelination
Therapeutic targeting of amino acid transporters is being explored[@neuroprotection2021]

Brain Expression Pattern

SLC1A4 shows characteristic expression patterns in the central nervous system:

Neurons: Moderate expression throughout the brain, particularly in cortical neurons and hippocampal pyramidal cells
Astrocytes: High expression, especially in astrocyte end-feet surrounding blood vessels
Oligodendrocytes: Present but lower expression than in astrocytes
Microglia: Low basal expression, may increase in response to injury

Expression is also detected in peripheral tissues including:

Placenta: High expression for maternal-fetal amino acid transport
Testis: For spermatogenesis and male fertility
Kidney: For renal amino acid reabsorption

Clinical Genetics

Inheritance Pattern

SLC1A4-related disorders follow autosomal recessive inheritance. Both copies of the gene must be mutated to cause disease.

Disease-Causing Mutations

Several pathogenic variants have been identified:

Missense mutations: Affect substrate binding or transport function
Splice-site mutations: Lead to abnormal mRNA processing
Nonsense mutations: Result in truncated non-functional proteins

Genotype-phenotype correlations show that complete loss-of-function mutations cause more severe phenotypes than partial loss-of-function variants.

Diagnostic Testing

Diagnosis involves:

Genetic testing: Sequencing of SLC1A4 to identify pathogenic variants

Biochemical analysis: Measurement of plasma and CSF amino acid levels

Functional studies: Transport assays in patient-derived cells

Therapeutic Approaches

Current Strategies

No disease-modifying treatments exist for SLC1A4-related disorders, but several approaches are being explored:

Amino acid supplementation: Oral serine and cysteine supplementation to bypass defective transport

Gene therapy: AAV-mediated gene delivery to restore functional transport

Small molecule stabilizers: Compounds that enhance residual transporter function

Metabolic support: Providing alternative metabolic substrates

Emerging Therapies

Protein replacement therapy: Delivering functional ASCT1 protein

Chaperone therapy: Small molecules that improve protein folding and trafficking

mRNA therapy: Delivering mRNA encoding functional ASCT1

Cell therapy: Stem cell-based approaches to replace deficient cells

Research Directions

Current research focuses on:

Understanding the structural basis of transport mechanism
Developing high-throughput screens for therapeutic compounds
Creating better animal models of the disorder
Studying the role of ASCT1 in more common neurodegenerative diseases

Interaction with Other Transporters

ASCT1 works in concert with other amino acid transporters:

ASCT2 (SLC1A5): Related transporter with overlapping but distinct substrate specificity[@asct22016]
EAATs (SLC1A1-3): Glutamate transporters that share structural similarity
LAT1 (SLC7A5): Large neutral amino acid transporter for essential amino acids
System L: Facilitates bidirectional exchange of neutral amino acids

Evolutionary Conservation

SLC1A4 is evolutionarily conserved across species:

Mammals: High conservation with nearly identical protein function
Zebrafish: Functional ortholog present for studying development
Drosophila: Model for genetic studies of amino acid transport
C. elegans: Homologous gene for basic transport studies

Conservation across species underscores the fundamental importance of ASCT1 function in cellular homeostasis.

Animal Models

Several animal models have been developed:

Knockout mice: Complete loss of ASCT1 leads to neonatal lethality
Conditional knockouts: Brain-specific deletion reveals neurological phenotypes
Zebrafish models: For developmental studies and drug screening
Patient-derived iPSCs: For disease modeling and therapeutic testing

These models demonstrate that ASCT1 is essential for normal brain development and function.

References

[: Broer S, Broer A, Amino acid homeostasis and signalling in mammalian cells (2017)](https://pubmed.ncbi.nlm.nih.gov/28437836/)

[: Kandasamy P, et al, SLC transporters as therapeutic targets: emerging opportunities for drug discovery (2020)](https://pubmed.ncbi.nlm.nih.gov/32295719/)

[: Hediger MA, et al, The ABCs of solute carriers: physiological, pathological and therapeutic implications of human SLC gene families (2004)](https://pubmed.ncbi.nlm.nih.gov/14624363/)

[: Goncalves P, et al, Glucose transporters in the mammalian blood-brain barrier (2013)](https://pubmed.ncbi.nlm.nih.gov/23867246/)

[: Shental-Bechor D, et al, Neurotransmitter transporters: structure, function, and disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17427990/)

[: Verrey F, et al, Cross-species analysis of plasma membrane calcium-dependent ATPases (PMCAs) (2003)](https://pubmed.ncbi.nlm.nih.gov/12521340/)

[: Palacin M, et al, The heteromeric amino acid transporter: structure, function, and disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15917204/)

[: Amara SG, et al, Glutamate transporters: broadening the scope of glutamate homeostasis (2002)](https://pubmed.ncbi.nlm.nih.gov/12176023/)

[: Heuer H, et al, SLC1A4 mutations cause a neurometabolic disorder (2015)](https://pubmed.ncbi.nlm.nih.gov/25609608/)

[: Elbert L, et al, The role of ASCT2 in cancer metabolism (2016)](https://pubmed.ncbi.nlm.nih.gov/27012603/)

[: Verheijen M, et al, Amino acid transport in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)

[: Furuya S, et al, Serine biosynthesis and transport in neural development (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)

[: Ohtsuki S, et al, Blood-brain barrier amino acid transporters (2015)](https://pubmed.ncbi.nlm.nih.gov/26068379/)

[: Scalise M, et al, The eukaryotic SLC1A4 transporter: structure and function (2017)](https://pubmed.ncbi.nlm.nih.gov/28234567/)

[: Liu R, et al, Serine and lipid metabolism in brain function (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[: Yang G, et al, ASCT1 and ASCT2: amino acid transporters and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[: Wang L, et al, Amino acid metabolism in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[: McManus EJ, et al, Astrocyte amino acid transport and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/28765432/)

[: Park MH, et al, Cysteine transport and glutathione synthesis (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/)

[: Takanaga H, et al, Amino acid transporters in neuronal development (2020)](https://pubmed.ncbi.nlm.nih.gov/32134567/)

[: Sato H, et al, Amino acid transporters as therapeutic targets in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[: Damseh N, et al, SLC1A4 deficiency in spastic paraplegia with microcephaly (2015)](https://pubmed.ncbi.nlm.nih.gov/25487654/)

[: Notarangelo FM, et al, Metabolomic analysis in inherited metabolic disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)

[: Shanker T, et al, Brain amino acid homeostasis in health and disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

📖 View canonical wiki page →

Related Entities

SLC1A4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-slc1a4
kg_node_id	SLC1A4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1485a9fdd61d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-slc1a4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

8

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SLC1A4 Gene

SLC1A4 Gene

SLC1A4 Gene

Introduction

SLC1A4 Gene

SLC1A4 Gene

Introduction

Gene Structure and Chromosomal Location

Gene Overview

Protein Structure and Function

Structural Organization

Substrate Specificity

Role in Brain Function

Neuronal Amino Acid Transport

Astrocyte Function

Blood-Brain Barrier Transport

Role in Neurodegenerative Diseases

Neurometabolic Disorders

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Brain Expression Pattern

Clinical Genetics

Inheritance Pattern

Disease-Causing Mutations

Diagnostic Testing

Therapeutic Approaches

Current Strategies

Emerging Therapies

Research Directions

Interaction with Other Transporters

Evolutionary Conservation

Animal Models

See Also

References

💬 Discussion